Skip to main content
. Author manuscript; available in PMC: 2014 Jul 16.
Published in final edited form as: Ann Surg Oncol. 2013 Mar 2;20(4):1056–1062. doi: 10.1245/s10434-012-2791-7

TABLE 3.

Univariate and multivariate analysis of progression-free and overall survival

Factor Progression-free survival
Overall survival
p value,
univariate
HR (95 % CI) and p value,
multivariate
p value,
univariate
HR (95 % CI) and p value,
multivariate
Age (per year) 0.3 1.02 (1.0–1.04)
p = 0.06
0.04 1.02 (1.0–1.04)
p = 0.1
Female gender 0.6 0.97 (0.7–1.5)
p = 0.9
0.02 0.9 (0.5–1.4)
p = 0.6
Recurrent disease 0.002 1.6 (1.1–2.5)
p = 0.02
0.3 1.2 (0.7–2.0)
p = 0.5
Symptomatic
 disease
0.1 1.2 (0.8–1.9)
p = 0.4
0.2 0.9 (0.5–1.6)
p = 0.7
High histologic
 grade
<0.0001 2.7 (1.7–4.3)
p < 0.0001
<0.0001 7.1 (3.9–13.0)
p < 0.0001
Preoperative SPCI
 (per point)
0.0002 1.08 (1.03–1.13)
p = 0.0007
0.002 1.1 (1.04–1.2)
p = 0.0009
Incomplete
cytoreduction
<0.0001 1.9 (1.2–3.0)
p = 0.005
<0.0001 1.3 (0.8–2.4)
p = 0.3
Lymph node
metastasis
<0.0001 1.9 (1.2–3.2)
p = 0.01
<0.0001 1.0 (0.5–1.8)
p = 1.0
Extensive CRS 0.09 0.9 (0.6–1.4)
p = 0.5
0.8 0.9 (0.5–1.6)
p = 0.7
Blood transfusion 0.09 1.5 (0.9–2.4)
p = 0.1
0.03 1.4 (0.8–2.6)
p = 0.3
Severe morbidity 0.5 0.9 (0.6–1.4)
p = 0.8
0.09 0.9 (0.5–1.6)
p = 0.7

HR hazard ratio, SPCI simplified peritoneal carcinomatosis index